Trial Profile
A study assessing effectiveness of OC000459 in the patients with Eosinophilic Asthma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Timapiprant (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 15 Dec 2015 New trial record